Levels of PAH-DNA adducts in placental tissue and the risk of fetal neural tube defects in a Chinese population

Reproductive Toxicology

Volumn 37, Issue , 2013, Pages 70-75

  Yuan, Yue ^a   Jin, Lei ^a   Wang, Linlin ^a   Li, Zhiwen ^a   Zhang, Le ^a   Zhu, Huiping ^b   Finnell, Richard H ^b   Zhou, Guodong ^c   Ren, Aiguo ^a  

^a PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

^b UNIVERSITY OF TEXAS AT AUSTIN   (United States)

^c TEXAS A AND M HEALTH SCIENCE CENTER   (United States)

Author keywords

DNA adducts; Fetus; Neural tube defects (NTDs); Placenta; Polycyclic aromatic hydrocarbons (PAHs)

Indexed keywords

DNA; POLYCYCLIC AROMATIC HYDROCARBON;

ADULT; ANENCEPHALUS; ARTICLE; CASE CONTROL STUDY; CHINESE; CONTROLLED STUDY; DELIVERY; DNA ADDUCT; DNA EXTRACTION; FEMALE; HUMAN; HUMAN TISSUE; INFANT; INTERACTIONS WITH DNA; MAJOR CLINICAL STUDY; NEURAL TUBE DEFECT; PLACENTA; PREGNANCY; RISK ASSESSMENT; SPINAL DYSRAPHISM;

ADULT; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; DNA ADDUCTS; ENVIRONMENTAL MONITORING; ENVIRONMENTAL POLLUTANTS; FEMALE; HUMANS; NEURAL TUBE DEFECTS; PLACENTA; POLYCYCLIC HYDROCARBONS, AROMATIC; PREGNANCY; RISK FACTORS;

EID: 84874769530     PISSN: 08906238     EISSN: 18731708     Source Type: Journal    
DOI: 10.1016/j.reprotox.2013.01.008     Document Type: Article

References (41)

1. Botto L.D., Moore C.A., Khoury M.J., Erickson J.D. Neural-tube defects. The New England Journal of Medicine 1999, 341:1509-1519.
2. Lazareff J.A. Neural Tube Defects 2009, World Scientific Pub Co. Inc., Singapore.
3. Christianson A.L., Howson C.P., Modell B. Global Report on Birth Defects: The hidden toll of dying and disabled children. March of Dimes Birth Defects Foundation 2006.
4. Li Z., Ren A., Zhang L., Ye R., Li S., Zheng J., et al. Extremely high prevalence of neural tube defects in a 4-county area in Shanxi Province, China. Birth Defects Research. Part A, Clinical and Molecular Teratology 2006, 76:237-240.
5. Barbieri O., Ognio E., Rossi O., Astigiano S., Rossi L. Embryotoxicity of benzo(a)pyrene and some of its synthetic derivatives in Swiss mice. Cancer Research 1986, 46:94-98.
6. Langlois P.H., Hoyt A.T., Lupo P.J., Lawson C.C., Waters M.A., Desrosiers T.A., et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons and risk of neural tube defect-affected pregnancies. Birth Defects Research. Part A, Clinical and Molecular Teratology 2012, 94:693-700.
7. Ren A., Qiu X., Jin L., Ma J., Li Z., Zhang L., et al. Association of selected persistent organic pollutants in the placenta with the risk of neural tube defects. Proceedings of the National Academy of Sciences of the United States of America 2011, 108:12770-12775.
8. Naufal Z., Li Z.W., Zhu L., Zhou G.D., McDonald T., He L.Y., et al. Biomarkers of exposure to combustion by-products in a human population in Shanxi, China. Journal of Exposure Science and Environmental Epidemiology 2010, 20:310-319.
9. Li Z., Zhang L., Ye R., Pei L., Liu J., Zheng X., et al. Indoor air pollution from coal combustion and the risk of neural tube defects in a rural population in Shanxi Province, China. American Journal of Epidemiology 2011, 174:451-458.
10. Sagiv S.K., Gaudet M.M., Eng S.M., Abrahamson P.E., Shantakumar S., Teitelbaum S.L., et al. Polycyclic aromatic hydrocarbon-DNA adducts and survival among women with breast cancer. Environmental Research 2009, 109:287-291.
11. Castano-Vinyals G., Talaska G., Rothman N., Alguacil J., Garcia-Closas M., Dosemeci M., et al. Bulky DNA adduct formation and risk of bladder cancer. Cancer Epidemiology, Biomarkers and Prevention 2007, 16:2155-2159.
12. Rybicki B.A., Rundle A., Savera A.T., Sankey S.S., Tang D. Polycyclic aromatic hydrocarbon-DNA adducts in prostate cancer. Cancer Research 2004, 64:8854-8859.
13. Vineis P., Perera F. DNA adducts as markers of exposure to carcinogens and risk of cancer. International Journal of Cancer 2000, 88:325-328.
14. Perera F.P., Wang S., Vishnevetsky J., Zhang B., Cole K.J., Tang D., et al. Polycyclic aromatic hydrocarbons-aromatic DNA adducts in cord blood and behavior scores in New York city children. Environmental Health Perspectives 2011, 119:1176-1181.
15. Perera F., Li T.Y., Zhou Z.J., Yuan T., Chen Y.H., Qu L., et al. Benefits of reducing prenatal exposure to coal-burning pollutants to children's neurodevelopment in China. Environmental Health Perspectives 2008, 116:1396-1400.
16. Perera F.P., Tang D., Rauh V., Lester K., Tsai W.Y., Tu Y.H., et al. Relationships among polycyclic aromatic hydrocarbon-DNA adducts, proximity to the World Trade Center, and effects on fetal growth. Environmental Health Perspectives 2005, 113:1062-1067.
17. Sram R.J., Binkova B., Dejmek J., Chvatalova I., Solansky I., Topinka J. Association of DNA adducts and genotypes with birth weight. Mutation Research 2006, 608:121-128.
18. 32P-postlabeling test for structurally diverse DNA adducts. Carcinogenesis 1986, 7:1543-1551.
19. Phillips D.H., Castegnaro M. Standardization and validation of DNA adduct postlabelling methods: report of interlaboratory trials and production of recommended protocols. Mutagenesis 1999, 14:301-315.
20. 32P-postlabeling assay for DNA adducts. Nature Protocols 2007, 2:2772-2781.
21. Liao Y., Wang J., Wu J., Driskell L., Wang W., Zhang T., et al. Spatial analysis of neural tube defects in a rural coal mining area. International Journal of Environmental Health Research 2010, 20:439-450.
22. Genuis S.J. Elimination of persistent toxicants from the human body. Human and Experimental Toxicology 2011, 30:3-18.
23. Shimada T. Xenobiotic-metabolizing enzymes involved in activation and detoxification of carcinogenic polycyclic aromatic hydrocarbons. Drug Metabolism and Pharmacokinetics 2006, 21:257-276.
24. Topinka J., Milcova A., Libalova H., Novakova Z., Rossner P., Balascak I., et al. Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part I: Bulky DNA adducts. Mutation Research 2009, 669:13-19.
25. Lupo P.J., Symanski E., Langlois P.H., Lawson C.C., Malik S., Gilboa S.M., et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons and congenital heart defects among offspring in the national birth defects prevention study. Birth Defects Research. Part A, Clinical and Molecular Teratology 2012, 94:875-881.
26. Lupo P.J., Langlois P.H., Reefhuis J., Lawson C.C., Symanski E., Desrosiers T.A., et al. Maternal occupational exposure to polycyclic aromatic hydrocarbons: effects on gastroschisis among offspring in the National Birth Defects Prevention Study. Environmental Health Perspectives 2012, 120:910-915.
27. Incardona J.P., Collier T.K., Scholz N.L. Defects in cardiac function precede morphological abnormalities in fish embryos exposed to polycyclic aromatic hydrocarbons. Toxicology and Applied Pharmacology 2004, 196:191-205.
28. Santodonato J. Review of the estrogenic and antiestrogenic activity of polycyclic aromatic hydrocarbons: Relationship to carcinogenicity. Chemosphere 1997, 34:835-848.
29. Nebert D.W., Dalton T.P. The role of cytochrome P450 enzymes in endogenous signalling pathways and environmental carcinogenesis. Nature Reviews Cancer 2006, 6:947-960.
30. Rossner P., Milcova A., Libalova H., Novakova Z., Topinka J., Balascak I., et al. Biomarkers of exposure to tobacco smoke and environmental pollutants in mothers and their transplacental transfer to the foetus. Part II. Oxidative damage. Mutation Research 2009, 669:20-26.
31. Viau C., Hakizimana G., Bouchard M. Indoor exposure to polycyclic aromatic hydrocarbons and carbon monoxide in traditional houses in Burundi. International Archives of Occupational and Environmental Health 2000, 73:331-338.
32. Tung E.W., Winn L.M. Valproic acid increases formation of reactive oxygen species and induces apoptosis in postimplantation embryos: a role for oxidative stress in valproic acid-induced neural tube defects. Molecular Pharmacology 2011, 80:979-987.
33. Herbstman J.B., Tang D., Zhu D., Qu L., Sjodin A., Li Z., et al. Prenatal exposure to polycyclic aromatic hydrocarbons. Benzo[a]pyrene-DNA adducts and genomic DNA methylation in cord blood. Environmental Health Perspectives 2012, 120:733-738.
34. Tang D., Li T.Y., Liu J.J., Chen Y.H., Qu L., Perera F. PAH-DNA adducts in cord blood and fetal and child development in a Chinese cohort. Environmental Health Perspectives 2006, 114:1297-1300.
35. Perera F., Hemminki K., Jedrychowski W., Whyatt R., Campbell U., Hsu Y., et al. In utero DNA damage from environmental pollution is associated with somatic gene mutation in newborns. Cancer Epidemiology, Biomarkers and Prevention 2002, 11:1134-1137.
36. Weston A., Bowman E.D., Shields P.G., Trivers G.E., Poirier M.C., Santella R.M., et al. Detection of polycyclic aromatic hydrocarbon-DNA adducts in human lung. Environmental Health Perspectives 1993, 99:257-259.
37. Vanschooten F.J., Hillebrand M.J.X., Vanleeuwen E.E., Vanzandwijk N., Jansen H.M., Denengelse L., et al. Polycyclic aromatic hydrocarbon DNA adducts in white blood-cells from lung-cancer patients - no correlation with adduct levels in lung. Carcinogenesis 1992, 13:987-993.
38. Agency for Toxic Substances and Disease Registry., Toxicological profile for polycyclic aromatic hydrocarbons (PAHs). 1995 [cited 2012 November 26]. Available from: http://www.atsdr.cdc.gov/toxprofiles/tp69.pdf.
39. Rice J.E., Hosted T.J., Lavoie E.J. Fluoranthene and pyrene enhance benzo[a]pyrene-DNA adduct formation in vivo in mouse skin. Cancer Letters 1984, 24:327-333.
40. Xu S., Liu W., Tao S. Emission of polycyclic aromatic hydrocarbons in China. Environmental Science and Technology 2006, 40:702-708.
41. Sanyal M.K., Mercan D., Belanger K., Santella R.M. DNA adducts in human placenta exposed to ambient environment and passive cigarette smoke during pregnancy. Birth Defects Research. Part A, Clinical and Molecular Teratology 2007, 79:289-294.